Cabazitaxel Spirig HC 60 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung - 3 ml Swissmedic Key 68959001 Registration Holder Spirig HealthCare AG Name Cabazitaxel Spirig HC 60 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung Date of registration 01.12.2022 Original/Generic Generic Introduction of Sequence 01.12.2022 ATC-Classification Cabazitaxel (L01CD04) Revision date WHO WHO-DDD Valid until 30.11.2027 Index Therapeuticus (BSV) 07.16.10. Show package size 3 ml Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 2447.84 Limitation Yes Limitation text
Deductible 10 % Consumer price 2690.90 Feedback FB GTIN 7680689590011 Medication Code Synthetika Pharmacode Disponibility
Composition cabazitaxelum 60 mg, polysorbatum 80, ethanolum anhydricum 1185 mg, acidum citricum, pro vitro. Packungsbestandteile Galenic Form Concentrate for infusion Excipiens Active Agent Dose Cabazitaxelum 60 mg
BAG: Active Agent Dose Cabazitaxelum 60 mg
Inactive agents Dose Citric Acid Ethanol Anhydrate 1185 mg Polysorbatum 80
Source Data was imported : 12.01.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
